Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 2/20 | 0.54 |
| ▸ | CCR4 | P51679 | 12/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NFKBIA | P25963 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5106613 | 0.88 | CCR4 (0.47) | CCR5CCR4KMT2AMEN1USP2 | |
| SCHEMBL5106108 | 0.82 | CCR5 (0.79) | CCR5CCR4KMT2AMEN1NFKBIA | |
| SCHEMBL5111149 | 0.81 | CCR4 (0.48) | CCR5CCR4KMT2AMEN1ALDH1A1 | |
| SCHEMBL5113238 | 0.80 | CCR5 (0.70) | CCR5CCR4KMT2AMEN1NFKBIA | |
| SCHEMBL6184367 | 0.74 | KDM4E (0.55) | CCR4KMT2AMEN1USP2ALDH1A1 | |
| SCHEMBL4683809 | 0.73 | CCR5 (0.75) | CCR5CCR4KMT2AMEN1ALDH1A1 | |
| SCHEMBL5099483 | 0.72 | CCR5 (1.00) | CCR5CCR4KMT2AMEN1NFKBIA | |
| SCHEMBL6038494 | 0.71 | KMT2A (0.50) | KMT2AMEN1ALDH1A1 | |
| SCHEMBL5103322 | 0.71 | CCR5 (0.71) | CCR5CCR4KMT2AMEN1PABPC1 | |
| SCHEMBL5111482 | 0.71 | CCR4 (0.76) | CCR5CCR4KMT2AMEN1NFKBIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1458715-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2004-09-22 | — | — | EP | claimed |
| WO-2003051870-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2003-06-26 | — | — | WO | claimed |